1. TRANSGENE BIOTEK LTD
stock logo

TRANSGENE BIOTEK LTD Share Price

TRABI

₹9.87+₹0.05 (0.51%) TodayLast updated on 25 Jul, 2024 | 15:29 IST
₹9.41₹10.05
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹72 Crs

Open

₹10.05

Close

₹9.82

Circuit range

₹10.31 - ₹9.33

Day range

₹9.41 - ₹10.05

Year range

₹3.62 - ₹12.46

Volume

35,637

Avg. traded

₹9.65

Revenue (12m)

₹0 Crs

TRANSGENE BIOTEK LTDTransgene Biotek Limited is an India-based biotechnology company. The Company is engaged in the research and development of vaccines, oncology and new drug delivery technologies. Its portfolio of products includes oncology, auto-immunity, drug delivery and biogenerics. The Company offers TrabiAAV, which is a platform for the delivery of micro ribonucleic acids (miRNAs), short hairpin RNA (ShRNAs), immunogens developing clinical significance in gene therapy and CRISPR/cas 9 technologies. Its monoclonal antibody therapy is the use of monoclonal antibodies to specifically bind to target cells. Its TrabiORAL is focused on delivering proteins and peptides orally for a variety of human diseases. Its TBL-1203, is used to strengthen cell-mediated immunity and complete elimination of the human immunodeficiency virus (HIV), without any need for retroviral drug therapy. Its Tacrolimus is a drug that suppresses the immune system and is mainly used to prevent rejection of transplanted organs.

TRANSGENE BIOTEK LTD Key indicators

arrow

52 week high

₹12.46

52 week low

₹3.62

P/E ratio

P/B ratio

7.08

ROE

--

ROCE

-57.49%

Dividend yield

--

Debt/Equity ratio

-2.11

EPS

-0.79

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

-789.22%

Net profit margin

0%

ROE

0%

ROA

-17.24%

ROCE

-57.49%

Learn more

TRANSGENE BIOTEK LTD Shareholder returns

arrow

1 day

+2.72%

1 week

-2.58%

1 month

+10.21%

3 months

+30.07%

1 year

+154.40%

3 years

+133.25%

5 years

+238.62%

TRANSGENE BIOTEK LTD Share Price history

arrow
DayOpenCloseDay’s change
Wed, Jul 24 2024
₹10.03
₹9.82
+2.72%
Tue, Jul 23 2024
₹9.99
₹9.56
-0.10%
Mon, Jul 22 2024
₹10.20
₹9.57
-1.54%
Fri, Jul 19 2024
₹10.09
₹9.72
-2.80%
Thu, Jul 18 2024
₹10.11
₹10.00
-0.79%
Tue, Jul 16 2024
₹10.48
₹10.08
-0.20%
Mon, Jul 15 2024
₹10.55
₹10.10
-2.42%
Fri, Jul 12 2024
₹10.00
₹10.35
+1.87%

Shareholding info

arrow

Promoters (23.64%)

Mutual Funds (0%)

Retail and other (76.36%)

Foreign institutions-FII (0%)

Other domestic institutions (0%)

Retail and other

Learn more

Frequently asked questions